Thu Sep 12 14:16:00 UTC 2024: ## Florida Cancer Specialists & Research Institute Presents Cutting-Edge Research at European Medical Oncology Congress

**FORT MYERS, Fla. – Sept. 12, 2024** – Florida Cancer Specialists & Research Institute (FCS) is showcasing its groundbreaking clinical research at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain. Six FCS physicians are leading authors of 20 cancer research studies that will be discussed at the conference, drawing attention from oncology professionals globally.

FCS, renowned for its extensive clinical trial program, is actively involved in transformative scientific discoveries aimed at improving cancer treatment and patient outcomes. “With more Phase 1 clinical trial patients than most academic centers across the country and a rapidly expanding late-phase clinical trials program, FCS is contributing to significant and transformative scientific discoveries that are advancing oncology practice,” stated Dr. Lucio N. Gordan, FCS president and managing physician.

The research presented at ESMO encompasses a wide range of cancer types and treatment modalities. Notably, Dr. [Name of Physician], a leading FCS researcher, will present two abstracts during oral presentations at the meeting. “We are excited to share our findings and engage in discussions with colleagues from around the world about how these discoveries can be translated into clinical practice and the design of future clinical trials,” said Dr. [Name of Physician].

FCS is committed to providing patients with access to innovative treatments and leading-edge research. The organization conducts over 180 early and late-phase clinical trials across its 30 research locations and three drug development units in Florida, serving over 600 patients annually. Partnerships with organizations like Sarah Cannon Research Institute (SCRI) and Paradigm Health, Inc. further enhance FCS’s ability to connect patients with suitable clinical trials.

The ESMO Congress 2024 serves as a global platform for oncologists, researchers, patient advocates, and healthcare industry representatives to discuss the latest advancements in oncology. All of the FCS study abstracts will be published online in the ESMO Congress 2024 Abstract Book, a supplement to the official ESMO journal, Annals of Oncology.

**About Florida Cancer Specialists & Research Institute, LLC:**

Florida Cancer Specialists & Research Institute (FCS) offers patients access to more clinical trials than any other private oncology practice in Florida. With a 40-year history of excellence, FCS is dedicated to providing exceptional and compassionate patient care, driven by innovative clinical research, cutting-edge technologies, and advanced treatments.

Read More